World's Best Scientists 2026 revealed!
Raphael Schiffmann

Raphael Schiffmann

D-Index & Metrics

Medicine

D-Index
101
Citations
32302
World Ranking
8056
National Ranking
4183

Raphael Schiffmann publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Raphael Schiffmann sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 421 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Raphael Schiffmann D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Raphael Schiffmann sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Raphael Schiffmann is affiliated with Baylor University in the United States. Their research primarily addresses topics in Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on several subfields including Physiology, Molecular Biology, Organic Chemistry, Cell Biology, and Rheumatology.

The scientist's work covers key research areas such as Lysosomal Storage Disorders Research, Carbohydrate Chemistry and Synthesis, Cellular transport and secretion, RNA regulation and disease, Glycogen Storage Diseases and Myoclonus, Studies on Chitinases and Chitosanases, and Trypanosoma species research and implications.

Raphael Schiffmann has published extensively in a variety of scientific journals. Frequent publication venues include Molecular Genetics and Metabolism, Journal of Inherited Metabolic Disease, Genetics in Medicine, Molecular Genetics and Metabolism Reports, and Neurology Genetics.

Notable recent papers authored or coauthored by Schiffmann include:

  • The definition of neuronopathic Gaucher disease, 2020, Journal of Inherited Metabolic Disease
  • Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial, 2022, Brain

Frequent coauthors in their collaborations include Derralynn Hughes, Jin-Song Shen, Özlem Göker-Alpan, Daniel G. Bichet, and Ellen Sidransky. These collaborations have contributed to the breadth and depth of Schiffmann's scientific output.

Best Publications

  • Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

    Raphael Schiffmann;Jeffrey B. Kopp;Howard A. Austin;Sharda Sabnis

  • Invited Article: An MRI-based approach to the diagnosis of white matter disorders

    Raphael Schiffmann;Marjo S. van der Knaap

  • Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant Sources

    Gregory A. Grabowski;Norman W. Barton;Gregory Pastores;James M. Dambrosia

  • Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.

    Mary H Branton;Raphael Schiffmann;Sharda G Sabnis;Gary J Murray

  • Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

    Dominique P Germain;Derralynn A Hughes;Kathleen Nicholls;Daniel G Bichet

  • Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation

    Gert C Scheper;Thom van der Klok;Rob J van Andel;Carola G M van Berkel

  • Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome

    Gillian Rice;Teresa Patrick;Rekha Parmar;Claire F Taylor

  • Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.

    Kenneth H. Kraemer;Nicholas J. Patronas;Raphael Schiffmann;Brian P. Brooks

  • Neuropathology provides clues to the pathophysiology of Gaucher disease

    Kondi Wong;Ellen Sidransky;Ajay Verma;Tonghui Mixon

  • Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel

    Mei Sun;Ehud Goldin;Stefanie Stahl;John L. Falardeau

  • Lamin B1 duplications cause autosomal dominant leukodystrophy

    Quasar S Padiath;Kazumasa Saigoh;Kazumasa Saigoh;Raphael Schiffmann;Hideaki Asahara

  • Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease

    R. Schiffmann;G. J. Murray;D. Treco;P. Daniel

  • Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

    Raphael J. Schiffmann;David G. Warnock;Maryam Banikazemi;Jan Bultas

  • Parkinsonism among Gaucher disease carriers.

    O Goker-Alpan;R Schiffmann;M E LaMarca;R L Nussbaum

  • Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

    Derralynn A Hughes;Kathleen Nicholls;Suma P Shankar;Gere Sunder-Plassmann

  • Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

    N. Tayebi;Jamie M Walker;B. Stubblefield;E. Orvisky

  • Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

    A. Mehta;M. Beck;P. Elliott;R. Giugliani

  • Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting

    Raphael Schiffmann;Markus Ries;Margaret Timmons;John T. Flaherty

  • Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy.

    David F. Moore;Leland T.C. Scott;Mark T. Gladwin;Gheona Altarescu

  • Childhood ataxia with diffuse central nervous system hypomyelination

    Raphael Schiffmann;Johanna R. Moller;Bruce D. Trapp;Henry H L Shih

Frequent Co-Authors

Roscoe O. Brady
Roscoe O. Brady Beth Israel Deaconess Medical Center
Derralynn Hughes
Derralynn Hughes Royal Free London NHS Foundation Trust
Daniel G. Bichet
Daniel G. Bichet University of Montreal
William R. Wilcox
William R. Wilcox Emory University
Roberto Giugliani
Roberto Giugliani Federal University of Rio Grande do Sul
Ellen Sidransky
Ellen Sidransky National Institutes of Health
David G. Warnock
David G. Warnock University of Alabama at Birmingham
Gioacchino Tedeschi
Gioacchino Tedeschi University of Campania "Luigi Vanvitelli"
Teodoro Bottiglieri
Teodoro Bottiglieri Baylor University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a medical career in the USA opens doors to various online degrees and advanced pathways. One popular choice for those interested in healthcare management is the top cahme accredited mha programs. These programs offer flexibility and a path to leadership roles in hospitals and healthcare organizations.

For registered nurses looking to advance their qualifications quickly, the rn to bsn with no clinicals option provides a streamlined route requiring minimal or no in-person clinicals. This makes it easier to balance work and study responsibilities.

Aspiring advanced practice nurses often seek out the fastest online dnp programs to accelerate their career progression and meet the growing demand for doctorally-prepared nurses. Similarly, some professionals look for easy dnp programs to efficiently gain their doctorate with a focus on manageable coursework and less intensive requirements.

Exploring these online education options can help you tailor a career in healthcare that fits your personal and professional goals, offering flexibility and a wide range of specialization choices.

Best Scientists Citing Raphael Schiffmann

Trending Scientists

Recently Published Articles